NL7206302A - - Google Patents

Info

Publication number
NL7206302A
NL7206302A NL7206302A NL7206302A NL7206302A NL 7206302 A NL7206302 A NL 7206302A NL 7206302 A NL7206302 A NL 7206302A NL 7206302 A NL7206302 A NL 7206302A NL 7206302 A NL7206302 A NL 7206302A
Authority
NL
Netherlands
Application number
NL7206302A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7206302A publication Critical patent/NL7206302A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL7206302A 1971-05-11 1972-05-10 NL7206302A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14241871A 1971-05-11 1971-05-11

Publications (1)

Publication Number Publication Date
NL7206302A true NL7206302A (enExample) 1972-11-14

Family

ID=22499766

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7206302A NL7206302A (enExample) 1971-05-11 1972-05-10

Country Status (9)

Country Link
US (2) US3681343A (enExample)
AU (1) AU472686B2 (enExample)
BE (1) BE783273A (enExample)
CH (3) CH573942A5 (enExample)
DE (1) DE2221790A1 (enExample)
FR (1) FR2137713B1 (enExample)
GB (2) GB1377435A (enExample)
NL (1) NL7206302A (enExample)
ZA (1) ZA722560B (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2156472A1 (de) 1970-11-23 1972-05-31 Ciba-Geigy Ag, Basel (Schweiz) Verfahren zur Herstellung von neuen Diazepinderivaten
JPS4932874B1 (enExample) * 1970-12-11 1974-09-03
CH545302A (de) * 1971-04-08 1974-01-13 Ciba Geigy Ag Verfahren zur Herstellung von neuen Triazolo-benzodiazepinderivaten
US3946032A (en) * 1971-04-08 1976-03-23 Ciba-Geigy Corporation Acetal derivatives of 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-carboxaldehyde
US4902794A (en) * 1971-04-28 1990-02-20 The Upjohn Company Triazolo-benzodiazepines
US4250094A (en) * 1971-04-28 1981-02-10 The Upjohn Company 1-(Aminoalkyl) substituted-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
DE2308280A1 (de) * 1971-11-15 1973-09-06 Ciba Geigy Ag Verfahren zur herstellung von neuen diazepinderivaten
US3886174A (en) * 1971-11-22 1975-05-27 Upjohn Co 1-Substituted-6-phenyl-4H-s-triazolo{8 4,3-a{9 {8 1,4{9 benzodiazepines
CH567031A5 (enExample) * 1972-05-18 1975-09-30 Ciba Geigy Ag
US3879406A (en) * 1972-07-13 1975-04-22 Hoffmann La Roche Preparation of triazolobenzodiazepines
IE38931B1 (en) * 1973-03-09 1978-07-05 Lipha Triazolobenzodiazepines
US4213982A (en) 1973-05-29 1980-07-22 E. R. Squibb & Sons, Inc. Novel 4H-S-triazolo[4,3-A] [1,5]benzodiazepin-5-ones
IE41197B1 (en) 1973-05-29 1979-11-07 Squibb & Sons Inc 4h-s-triazolo (4,3-a)(1,5)benzodiazepin-5-ones
AT338799B (de) 1974-03-02 1977-09-12 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer substituierter 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepine und ihrer salze
JPS5747914B2 (enExample) * 1974-04-12 1982-10-13
US3910944A (en) * 1974-11-20 1975-10-07 Upjohn Co Spiro(cyclopropane-1,4{40 -(4H)-s-triazolo-(4,3-a)(1,4)benzodiazepines)
US4044016A (en) * 1975-01-13 1977-08-23 Hoffmann-La Roche Inc. Preparation of triazolo benzodiazepines and novel compounds
US4018788A (en) * 1975-06-16 1977-04-19 The Upjohn Company 6-(O-Halophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepine
US4226772A (en) * 1976-03-15 1980-10-07 The Upjohn Company 1-[(Dialkylamino)methyl]-6-phenyl-4H-s-[4,3,-a][1,4]triazolobenzodiazepine N1 -oxide
US4009175A (en) * 1976-03-15 1977-02-22 The Upjohn Company 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines
US4415583A (en) * 1980-03-27 1983-11-15 The Upjohn Company Process for inducing hypnosis
US4374842A (en) * 1980-04-18 1983-02-22 Shionogi & Co., Ltd. 4,1-Benzoxazepines and compositions
US4479959A (en) * 1981-01-29 1984-10-30 The Upjohn Company Process for inducing hypnosis
US4444781A (en) * 1981-04-06 1984-04-24 The Upjohn Company Process for inducing hypnosis
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
MX354217B (es) 2010-05-14 2018-02-19 Dana Farber Cancer Inst Inc Composiciones y metodos para el tratamiento de leucemia.
PL2902030T3 (pl) * 2010-05-14 2017-07-31 Dana-Farber Cancer Institute, Inc. Związki tienotriazolodiazepinowe do leczenia nowotworu
EP2571875A4 (en) 2010-05-14 2013-10-30 Dana Farber Cancer Inst Inc CONTRACEPTIVE COMPOSITIONS FOR MEN AND METHODS OF USE THEREOF
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9422292B2 (en) 2011-05-04 2016-08-23 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
US9975896B2 (en) 2013-07-25 2018-05-22 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
RU2016122654A (ru) 2013-11-08 2017-12-14 Дана-Фарбер Кэнсер Инститьют, Инк. Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка
EP3099677A4 (en) 2014-01-31 2017-07-26 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
JP2017506666A (ja) 2014-02-28 2017-03-09 テンシャ セラピューティクス,インコーポレイテッド 高インスリン血症に関連した症状の処置
PL3157928T3 (pl) 2014-06-20 2019-07-31 Constellation Pharmaceuticals, Inc. Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu
CN106793775B (zh) 2014-08-08 2020-06-02 达纳-法伯癌症研究所股份有限公司 二氢碟啶酮衍生物及其用途
CN106715437A (zh) 2014-08-08 2017-05-24 达纳-法伯癌症研究所股份有限公司 二氮杂环庚烷衍生物及其用途
KR20170068597A (ko) 2014-10-27 2017-06-19 텐샤 세러퓨틱스 인코포레이티드 브로모도메인 저해제
WO2016201370A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
RU2018112953A (ru) 2015-09-11 2019-10-14 Дана-Фарбер Кэнсер Инститьют, Инк. Ацетамидтиенотриазолодиазепины и пути их применения
EP3347021A4 (en) 2015-09-11 2019-07-24 Dana-Farber Cancer Institute, Inc. CYANOTHIENOTRIAZOLDIAZEPINE AND USES THEREOF
MX2018006499A (es) 2015-11-25 2018-08-01 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos.
CN110769830A (zh) 2017-05-12 2020-02-07 马瓦隆治疗有限公司 作为ii组代谢型谷氨酸受体的别构调节剂的取代的杂环化合物
UA129503C2 (uk) * 2020-03-31 2025-05-14 Ф. Хоффманн-Ля Рош Аг ПОХІДНІ БЕНЗОДІАЗЕПІНУ ЯК ПОЗИТИВНІ АЛОСТЕРИЧНІ МОДУЛЯТОРИ ГАМК<sub>A</sub> ГАММА-1
JP2024537773A (ja) 2021-09-29 2024-10-16 エフ. ホフマン-ラ ロシュ アーゲー GABA Aγ1 PAMとしての新規ベンゾジアゼピン誘導体
KR20240073892A (ko) 2021-10-06 2024-05-27 에프. 호프만-라 로슈 아게 Gaba a gamma1 수용체의 양성 알로스테릭 조절인자로서의 벤조디아제핀 유도체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH540247A (de) * 1967-04-21 1973-09-28 Ciba Geigy Ag Verfahren zur Herstellung von heterocyclischen, Asthylendoppelbindungen enthaltenden Verbindungen
JPS4837280B1 (enExample) * 1969-03-08 1973-11-09
YU34997B (en) * 1970-03-27 1980-06-30 Hiroyuki Tawada Process for preparing benzodiazepine derivatives

Also Published As

Publication number Publication date
CH582180A5 (enExample) 1976-11-30
ZA722560B (en) 1973-02-28
AU4164072A (en) 1973-11-01
BE783273A (fr) 1972-11-10
GB1380880A (en) 1975-01-15
FR2137713A1 (enExample) 1972-12-29
USRE28505E (en) 1975-08-05
FR2137713B1 (enExample) 1975-12-26
GB1377435A (en) 1974-12-18
DE2221790A1 (de) 1972-11-23
AU472686B2 (en) 1976-06-03
CH573942A5 (enExample) 1976-03-31
US3681343A (en) 1972-08-01
CH572485A5 (enExample) 1976-02-13

Similar Documents

Publication Publication Date Title
ATA136472A (enExample)
AR196074A1 (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU2952271A (enExample)
AU2941471A (enExample)
AU2894671A (enExample)
AU2742671A (enExample)
AU2726271A (enExample)
AU2485671A (enExample)
AU2684071A (enExample)
AU3005371A (enExample)
AU2564071A (enExample)
AU2473671A (enExample)
AU2836771A (enExample)
AU2577671A (enExample)
AU2503871A (enExample)
AU2854371A (enExample)
AU3038671A (enExample)
AU2588771A (enExample)
AU2654071A (enExample)
AU3025871A (enExample)
AU2669471A (enExample)
AU2456871A (enExample)
AU2684171A (enExample)

Legal Events

Date Code Title Description
BV The patent application has lapsed